## ALL: The Allstate Corporation - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.24 indicates fundamental undervaluation. Quality metrics strong (ROE 34%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-5.0% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($201.56)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Allstate (ALL) president exercises $62.32 options, sells stock at ~$215 in 10b5-1 trades**
- Source: Stock Titan | 20251202T040907 | Somewhat-Bearish | Relevance: 100%
- Suren Gupta, President of Enterprise Solutions at The Allstate Corporation, exercised employee stock options to purchase 4,536 shares of Allstate common stock at $62.32 per share across two dates in late November 2025. Concurrently, he sold the same number of shares on the open market at weighted average prices of approximately $215, all in accordance with a Rule 10b5-1(c) trading plan established on June 9, 2025. After these transactions, Gupta directly beneficially owns 100,646 Allstate shares and retains 19,593 employee stock options.

**2. How to Cancel Your Allstate Auto Insurance Policy in 5 Easy Steps (2025)**
- Source: Insurify | 20251202T090750 | Neutral | Relevance: 100%
- This article outlines a five-step process for canceling an Allstate auto insurance policy. It emphasizes the importance of comparing new quotes and securing a new policy before canceling with Allstate to avoid a coverage lapse, as Allstate does not offer online cancellations and requires direct contact with customer service or an agent. The guide also details how to track potential refunds after cancellation.

**3. Korea Investment CORP Sells 58,400 Shares of Aptiv PLC $APTV**
- Source: MarketBeat | 20251203T113623 | Neutral | Relevance: 75%
- Korea Investment CORP reduced its stake in Aptiv PLC by 32.3% in the second quarter, selling 58,400 shares and now owning 122,228 shares valued at $8.34 million. Despite the institutional selling, Wall Street analysts maintain a "Moderate Buy" consensus with an average price target of $95.42. Aptiv also reported strong quarterly earnings, beating estimates with $2.17 EPS and $5.21 billion in revenue, and provided optimistic FY2025 guidance.

**4. 10 Largest Auto Insurance Companies (December 2025)**
- Source: ValuePenguin | 20251202T120842 | Neutral | Relevance: 73%
- This article identifies the 10 largest auto insurance companies in the U.S. for December 2025, with State Farm leading the market share. It provides detailed profiles of each company, including their market share, premiums, customer satisfaction ratings, and key features. The article also offers a comparison between large and small insurance companies and expert insights on market perception, customer satisfaction, and the role of localized agents in the digital age.

**5. AI & the Future of the Insurance Industry**
- Source: EPAM | 20251203T112822 | Somewhat-Bullish | Relevance: 70%
- This article discusses the future of AI in the insurance industry, drawing insights from a panel discussion at ITC Vegas 2025. Key challenges highlighted include legacy systems, data quality issues, and the need for effective change management. The experts emphasize the importance of clean data, strategic use cases, and addressing people/culture aspects for successful AI adoption.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 6, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-26 | Roth Capital | $240 | $230 | +4% |
| 2025-11-11 | Keefe, Bruyette | $250 | $246 | +2% |
| 2025-11-10 | UBS | $255 | $250 | +2% |
| 2025-11-07 | Wells Fargo | $216 | $202 | +7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-26 | Roth Capital | main | Buy |
| 2025-11-11 | Keefe, Bruyette | main | Outperform |
| 2025-11-10 | UBS | main | Buy |
| 2025-11-07 | Wells Fargo | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.16M) |
| Sells | 13 ($14.04M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (-0.3%)
- Blackrock Inc.: 8.5% (-1.0%)
- Price (T.Rowe) Assoc: 4.9% (-17.0%)
- State Street Corpora: 4.5% (+0.7%)
- Geode Capital Manage: 2.7% (+3.3%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-5.0% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $14M sold (13 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 6 raises (avg +4%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 1.24 suggests fair value with growth premium. Quality metrics strong (ROE 34%). Balance sheet: strong liquidity (30938000000.0x), $3.2B free cash flow. Insider selling cluster ($14.0M in 90 days), potential headwind. Institutional flow bearish (8 selling vs 2 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $54.8B |
| Beta | 0.25 |
| 52W Range | $176.00 - $215.89 |
| Short Interest | 1.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.24 |
| Forward P/E | 8.7 |
| Current P/E | 7.2 |
| YoY Growth | -17.1% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 3.4% to -1.6% (-5.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.6pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.04x) but short-term weakness (below SMA20). RSI neutral at 53. OFD pattern: -SBN (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.58% (CS: 35) | Neutral |
| RSI_14 | 53.1 | Neutral |
| MACD Histogram | -0.31 | Bearish |
| vs SMA20 | 0.999x | Below |
| vs SMA50 | 1.019x | Above |
| vs SMA200 | 1.036x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $208.62
- **Stop Loss:** $201.56 (3.4% risk)
- **Target:** $222.74 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 134
- **Position Value:** $27,955.08
- **Portfolio %:** 27.96%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-04 (Est: $8.25)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $7.54 | $11.17 | +48.1% |
| 2025Q2 | $3.26 | $5.94 | +82.4% |
| 2025Q1 | $2.53 | $3.53 | +39.3% |
| 2024Q4 | $6.28 | $7.67 | +22.1% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*